Tag: Eli Lilly
Trump’s GLP-1 Drug Deal with Eli Lilly and Novo Nordisk Falls Short of Cost Control Goals
The Trump administration's voluntary pricing agreement with Eli Lilly and Novo Nordisk to control GLP-1 drug costs contains structural loopholes…
Eli Lilly Reports Safety Data for Next-Generation Obesity Drug Retatrutide
Eli Lilly presented new safety data for retatrutide, its triple-hormone obesity drug, at the 2026 American Diabetes Association meeting. The…
Submit Your Paper to GMJ
No APC until January 2027.